Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)
Open Access
- 1 November 2012
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 53 (11), 2413-2424
- https://doi.org/10.1194/jlr.m030411
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradationBMC Pharmacology, 2012
- FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and SignalingCell Metabolism, 2012
- The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and DiseaseChemical Reviews, 2011
- Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid MetabolismAmerican Journal of Human Genetics, 2010
- The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptorsNature Neuroscience, 2010
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer PathogenesisCell, 2010
- Discovery of Potent and Reversible Monoacylglycerol Lipase InhibitorsCell Chemical Biology, 2009
- Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profilingBioorganic & Medicinal Chemistry Letters, 2008
- Activation of the endocannabinoid system by organophosphorus nerve agentsNature Chemical Biology, 2008
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolCell Chemical Biology, 2007